A SYSTEMATIC LITERATURE REVIEW AND METAANALYSIS OF WORK PRODUCTIVITY IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS TREATED WITH BIOLOGIC OR TARGETED SYNTHETIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS

被引：0
|
作者：
Rudwaleit, M. [1 ]
Morup, M. [2 ]
Humphries, B. [3 ]
Zannat, N. E. [3 ]
Willems, D. [4 ]
Taieb, V [5 ]
Boonen, A. [6 ,7 ]
机构：
[1] Univ Bielefeld, Bielefeld, Germany
[2] UCB Pharma, Copenhagen, Denmark
[3] Cytel Inc, Waltham, MA USA
[4] UCB Pharma, Brussels, Belgium
[5] UCB Pharma, Colombes, France
[6] Maastricht Univ, Med Ctr, Maastricht, Netherlands
[7] Maastricht Univ, Maastricht, Netherlands
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
SA2
引用
收藏
页码：S397 / S397
页数：1
相关论文
共 50 条
  • [1] Work productivity in patients with axial spondyloarthritis initiating biological or targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review and meta-analysis
    Rudwaleit, Martin
    Morup, Michael
    Humphries, Brittany
    Zannat, Noor-E
    Willems, Damon
    Taieb, Vanessa
    Boonen, Annelies
    RMD OPEN, 2023, 9 (04):
  • [2] The Effect of Biologic Disease-Modifying Antirheumatic Drugs in Targeting Disease Remission in Axial Spondyloarthritis: A Systematic Literature Review
    Machado, Ana Rita
    Manica, Santiago Rodrigues
    Silva, Joana Leite
    Pimentel-Santos, Fernando
    Costa, Jose Tavares
    Vieira-Sousa, Elsa
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [3] Targeted synthetic disease-modifying antirheumatic drugs in spondyloarthritis
    Wendling, Daniel
    Prati, Clement
    IMMUNOTHERAPY, 2017, 9 (03) : 221 - 223
  • [4] THE EFFECT OF BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN TARGETING DISEASE REMISSION IN AXIAL SPONDYLOARTHRITIS (AXSPA): A SYSTEMATIC LITERATURE REVIEW
    Cruz-Machado, A. R.
    Manica, S. R.
    Silva, J. L.
    Pimentel-Santos, F. M.
    Tavares-Costas, J.
    Vieira-Sousa, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 998 - 999
  • [5] THE EFFECT OF BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS PATIENT REPORTED OUTCOMES IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS; A SYSTEMATIC LITERATURE REVIEW AND A CALL FOR ACTION
    Rodrigues-Manica, S.
    Leite Silva, J.
    Machado, A. R.
    Coelho, C.
    Duarte, J.
    Vieira-Sousa, E.
    Tavares-Costa, J.
    Pimentel-Santos, F. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1550 - 1551
  • [6] The Effect of Biologic Disease-Modifying Antirheumatic Drugs in Patient Reported Outcomes in Axial Spondyloarthritis; A Systematic Literature Review and a Call for Action
    Manica, Santiago Rodrigues
    Silva, Joana Leite
    Machado, Ana Rita
    Coelho, Constanca
    Duarte, Joana
    Vieira-Sousa, Elsa
    Costa, Jose Tavares
    Pimentel-Santos, Fernando
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [7] THE EFFECT OF BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (bDMARDs) IN TARGETING DISEASE REMISSION IN AXIAL SPONDYLOARTHRITIS (axSpA): A SYSTEMATIC LITERATURE REVIEW (SLR)
    Cruz-Machado, A. R.
    Manica, S. R.
    Silva, J. L.
    Pimentel-Santos, F. M.
    Tavares-Costa, J.
    Vieira-Sousa, E.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (04) : 731 - 731
  • [8] Deciding who to treat with biologic disease-modifying antirheumatic drugs in axial spondyloarthritis
    Wendling, Daniel
    Goupille, Philippe
    IMMUNOTHERAPY, 2020, 12 (12) : 857 - 860
  • [9] An overview of biologic disease-modifying antirheumatic drugs in axial spondyloarthritis and psoriatic arthritis
    So, Anthony
    Inman, Robert Davies
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2018, 32 (03): : 453 - 471
  • [10] Incidence of Interstitial Lung Disease in Patients With Rheumatoid Arthritis Treated With Biologic and Targeted Synthetic Disease-Modifying Antirheumatic Drugs
    Baker, Matthew C.
    Liu, Yuhan
    Lu, Rong
    Lin, Janice
    Melehani, Jason
    Robinson, William H.
    JAMA NETWORK OPEN, 2023, 6 (03)
12345